A European Multi-Center, Randomized, Double-Blind Trial of Pirfenidone in Bronchiolitis-Obliterans-Syndrome Grade 1-3 in Lung Transplant Recipients (European Trial of Pirfenidone in BOS (EPOS))

OF OBJECTIVES: Bronchiolitis obliterans syndrome (BOS), the most common form of chronic lung allograft dysfunction (CLAD), and the major limitation to long-term survival after lung transplantation. BOS affects up to 50% of lung transplant recipients within 5 years after transplant, causing significa...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	Perch, M, Besa, V, Corris, P.A, Iversen, M, Kneidinger, N, Leuckfeld, I, Lordan, J, Magnusson, J, Verleden, G.M, Verschuuren, E, Vos, R, Gottlieb, J
Format:	Other
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!